ADIAL PHARMACEUTICALS, INC. (ADIL)
About ADIAL PHARMACEUTICALS, INC.
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its investigational new drug candidate, AD04, is being developed as a therapeutic agent for the treatment of alcohol use disorder. The company operates as one operating segment with a focus on drug development for addiction and related disorders.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Net income
- -$8.0M
- Total assets
- $6.7M
- Market cap
- $4.7M
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $0
- Operating expenses
- $7.8M
- Operating income
- -$7.8M
- Net income
- -$8.0M
- EPS (basic)
- $-11.93
- EPS (diluted)
- $-11.93
Balance sheet
- Total assets
- $6.7M
- Current assets
- $6.2M
- Total liabilities
- $1.4M
- Current liabilities
- $1.4M
- Shareholders’ equity
- $5.3M
Cash flow
- Operating cash flow
- -$6.5M
- Investing cash flow
- -$2.0M
- Financing cash flow
- $8.5M
- Net cash flow
- $0
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $4.7M
- EPS (diluted)
- $-11.93
- Shares outstanding
- 1.7M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jul 27, 2018
Adial Pharmaceuticals, Inc. (ADIL) Stock Price
- Reported a net loss of $8.0M.
- Trading 82% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review ADIAL PHARMACEUTICALS, INC..
Write a review
News about ADIAL PHARMACEUTICALS, INC.
News & sentiment via Polygon.io
Adial Pharmaceuticals, Inc.: frequently asked questions
Is Adial Pharmaceuticals, Inc. an American company?
Adial Pharmaceuticals, Inc. is a US-based company headquartered in Charlottesville, Virginia, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Adial Pharmaceuticals, Inc. headquartered?
Adial Pharmaceuticals, Inc. is headquartered in Charlottesville, Virginia, United States.
Is Adial Pharmaceuticals, Inc. publicly traded?
Yes — Adial Pharmaceuticals, Inc. is a publicly traded company. Its stock trades under the ticker symbol ADIL on the NASDAQ.
What does Adial Pharmaceuticals, Inc. do?
Adial Pharmaceuticals, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
